NCT03232112View on ClinicalTrials.gov

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

March 15, 2020

Study Completion Date

October 5, 2020

Conditions
Alcohol Dependence, in RemissionAddiction, Alcohol
Interventions
DRUG

Exenatide 2 MG Injection

Subcutaneous injection once-weekly

DRUG

BD PosiFlush (saline)

Subcutaneous injection once-weekly

Trial Locations (1)

2000

Novavì ambulatorierne, Copenhagen

All Listed Sponsors
collaborator

The Novavì outpatient clinics, Copenhagen

UNKNOWN

collaborator

Neurobiology Research Unit, Rigshospitalet, Copenhagen

UNKNOWN

collaborator

Section of Biostatistics University of Copenhagen, Copenhagen

UNKNOWN

lead

Anders Fink-Jensen, MD, DMSci

OTHER

NCT03232112 - Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence? | Biotech Hunter | Biotech Hunter